Moreover, given the complexity of immune processes, we advocate moving away from the concept of a single immunological marker (whether it is CRP or another) able to detect the entire biological modifications involved in the immune-related MDD phenotypes, and instead use a systems immunology approach [56]. This evidence concerns the gene CRP and major depressive disorder.